New Sepsis Diagnostics and Their Impacts on Clinical Decision-Making and Treatment Protocols
Clin Chem
.
2024 Feb 7;70(2):361-367.
doi: 10.1093/clinchem/hvad211.
Authors
Allison B Chambliss
1
,
Sridevi Devaraj
2
,
Jeremiah S Hinson
3
,
Sophie E Katz
4
,
Russell B Kerbel
5
,
Nathan A Ledeboer
6
Affiliations
1
Associate Professor, Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA, United States.
2
Professor, Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States.
3
Associate Professor, Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
4
Assistant Professor, Department of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States.
5
Associate Professor, Department of Medicine, University of California Los Angeles, Los Angeles, CA, United States.
6
Professor, Department of Pathology and Laboratory Medicine, Medical College of Wisconsin, Milwaukee, WI, United States.
PMID:
38170198
DOI:
10.1093/clinchem/hvad211
No abstract available
MeSH terms
Clinical Decision-Making
Clinical Protocols
Humans
Sepsis* / drug therapy